W. Rhys‐Williams

754 total citations
28 papers, 642 citations indexed

About

W. Rhys‐Williams is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, W. Rhys‐Williams has authored 28 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Infectious Diseases and 5 papers in Organic Chemistry. Recurrent topics in W. Rhys‐Williams's work include Antimicrobial Resistance in Staphylococcus (7 papers), Analytical Chemistry and Chromatography (5 papers) and Bacterial biofilms and quorum sensing (4 papers). W. Rhys‐Williams is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Analytical Chemistry and Chromatography (5 papers) and Bacterial biofilms and quorum sensing (4 papers). W. Rhys‐Williams collaborates with scholars based in United Kingdom, United States and Switzerland. W. Rhys‐Williams's co-authors include William G. Love, David J. Farrell, M J Robbins, Nicola Ooi, Keith Miller, I. Chopra, W. Love, Peter A. Williams, Stephen Taylor and Andrew W. Lloyd and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the New York Academy of Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

W. Rhys‐Williams

28 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Rhys‐Williams United Kingdom 13 300 106 93 75 72 28 642
Sanil D. Singh South Africa 19 257 0.9× 239 2.3× 101 1.1× 84 1.1× 17 0.2× 45 907
Philipp Uhl Germany 17 424 1.4× 85 0.8× 182 2.0× 63 0.8× 17 0.2× 58 876
Michele Scian United States 14 637 2.1× 48 0.5× 75 0.8× 68 0.9× 22 0.3× 24 1.0k
Yanxia Wu China 13 498 1.7× 104 1.0× 46 0.5× 293 3.9× 66 0.9× 38 1.0k
Toshiki G. Nakashige United States 12 406 1.4× 133 1.3× 60 0.6× 174 2.3× 25 0.3× 15 837
Alejandro A. Hidalgo Chile 15 240 0.8× 77 0.7× 22 0.2× 117 1.6× 47 0.7× 37 711
Qing Wu China 15 162 0.5× 117 1.1× 30 0.3× 217 2.9× 43 0.6× 40 627
Catharine A. Trieber Canada 23 729 2.4× 193 1.8× 25 0.3× 182 2.4× 78 1.1× 34 1.4k
Abigail González‐Valdez Mexico 16 514 1.7× 25 0.2× 64 0.7× 119 1.6× 128 1.8× 52 971
Arthur L. James United Kingdom 18 373 1.2× 63 0.6× 45 0.5× 40 0.5× 32 0.4× 46 780

Countries citing papers authored by W. Rhys‐Williams

Since Specialization
Citations

This map shows the geographic impact of W. Rhys‐Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Rhys‐Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Rhys‐Williams more than expected).

Fields of papers citing papers by W. Rhys‐Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Rhys‐Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Rhys‐Williams. The network helps show where W. Rhys‐Williams may publish in the future.

Co-authorship network of co-authors of W. Rhys‐Williams

This figure shows the co-authorship network connecting the top 25 collaborators of W. Rhys‐Williams. A scholar is included among the top collaborators of W. Rhys‐Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Rhys‐Williams. W. Rhys‐Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rhys‐Williams, W., et al.. (2023). Antimicrobial effects of XF drugs against Candida albicans and its biofilms. SHILAP Revista de lepidopterología. 4. 1225647–1225647. 3 indexed citations
2.
Rhys‐Williams, W., et al.. (2023). Screening of the novel antimicrobial drug, XF-73, against 2,527 Staphylococcus species clinical isolates. Frontiers in Cellular and Infection Microbiology. 13. 1264456–1264456. 1 indexed citations
3.
Rhys‐Williams, W., et al.. (2022). Antibacterial and Antibiofilm Potency of XF Drugs, Impact of Photodynamic Activation and Synergy With Antibiotics. Frontiers in Cellular and Infection Microbiology. 12. 904465–904465. 5 indexed citations
4.
Vaudaux, Pierre, Elzbieta Huggler, W. Rhys‐Williams, William G. Love, & Daniel P. Lew. (2011). Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents. 37(6). 576–579. 9 indexed citations
5.
Sheerin, Angela N., S. K. Smith, Marcus Allen, et al.. (2011). Characterization of cellular senescence mechanisms in human corneal endothelial cells. Aging Cell. 11(2). 234–240. 26 indexed citations
6.
Farrell, David J., M J Robbins, W. Rhys‐Williams, & William G. Love. (2010). In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species. International Journal of Antimicrobial Agents. 35(6). 531–536. 42 indexed citations
7.
Farrell, David J., M J Robbins, W. Rhys‐Williams, & William G. Love. (2010). Investigation of the Potential for Mutational Resistance to XF-73, Retapamulin, Mupirocin, Fusidic Acid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus Isolates during a 55-Passage Study. Antimicrobial Agents and Chemotherapy. 55(3). 1177–1181. 79 indexed citations
8.
Szilágyi, Andrea, Richard L. Gamelli, David W. Hecht, et al.. (2010). The Novel Antibacterial Drug XF-70 is a Potent Inhibitor of Staphylococcus aureus Infection of the Burn Wound. Journal of Burn Care & Research. 31(3). 462–469. 3 indexed citations
9.
Ooi, Nicola, Keith Miller, Joanne K. Hobbs, et al.. (2009). XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity. Journal of Antimicrobial Chemotherapy. 64(4). 735–740. 77 indexed citations
10.
Ooi, Nicola, Keith Miller, Christopher P. Randall, et al.. (2009). XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. Journal of Antimicrobial Chemotherapy. 65(1). 72–78. 78 indexed citations
11.
Burton, Dominick G. A., Peter Giles, Angela N. Sheerin, et al.. (2009). Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification. Experimental Gerontology. 44(10). 659–665. 90 indexed citations
12.
Burton, Dominick G. A., Angela N. Sheerin, Elizabeth L. Ostler, et al.. (2007). Cyclin D1 Overexpression Permits the Reproducible Detection of Senescent Human Vascular Smooth Muscle Cells. Annals of the New York Academy of Sciences. 1119(1). 20–31. 40 indexed citations
13.
Merolli, Antonio, Michela Bosetti, Andrew W. Lloyd, et al.. (2006). In vivo assessment of the osteointegrative potential of phosphatidylserine-based coatings. Journal of Materials Science Materials in Medicine. 17(9). 789–794. 19 indexed citations
14.
Santin, Matteo, W. Rhys‐Williams, Martyn C. Davies, et al.. (2005). Calcium-binding phospholipids as a coating material for implant osteointegration. Journal of The Royal Society Interface. 3(7). 277–281. 23 indexed citations
15.
Lloyd, Andrew W., Richard Faragher, W. Rhys‐Williams, et al.. (2000). Assessing the in vitro cell based ocular compatibility of contact lens materials. Contact Lens and Anterior Eye. 23(4). 119–123. 15 indexed citations
16.
Rhys‐Williams, W., et al.. (1998). Extent of chiral inversion of the 2‐arylpropionic acids by Cordyceps militaris. Chirality. 10(6). 528–534. 6 indexed citations
17.
Rhys‐Williams, W., et al.. (1997). A mechanistic investigation of the microbial chiral inversion of 2-phenylpropionic acid byVerticillium lecanii. Chirality. 9(3). 254–260. 7 indexed citations
18.
Rhys‐Williams, W., et al.. (1997). Indirect enantiomeric separation of 2-arylpropionic acids and structurally related compounds by reversed phase HPLC. Journal of Pharmaceutical and Biomedical Analysis. 15(11). 1765–1774. 12 indexed citations
19.
Rhys‐Williams, W., et al.. (1996). Demonstration of the Chiral Inversion of 2‐Phenylpropionic Acid by Cell Extracts from Verticillium lecanii. Pharmacy and Pharmacology Communications. 2(11). 537–540. 2 indexed citations
20.
Rhys‐Williams, W., Stephen Taylor, & Peter A. Williams. (1993). A novel pathway for the catabolism of 4-nitrotoluene by Pseudomonas. Journal of General Microbiology. 139(9). 1967–1972. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026